FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Authority Hl7

31,787 resources

Source: Text:

By Version

By Realm

 

Start Prev Rows 1800 - 2000 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1509.jsonArsenic Exposure and Toxicity (Tests for Arsenic [Quantitative] in Unspecified Specimen)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1513.jsonUrine (Specimen Type) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1514.jsonMercury Exposure and Toxicity (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1515.jsonCryptococcosis (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1516.jsonCryptococcosis (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1520.jsonCryptococcosis (Tests for Cryptococcus species by Culture and Identification Method)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1523.jsonCryptococcosis (Tests for Cryptococcus species Nucleic Acid)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1524.jsonCryptococcosis (Tests for Cryptococcus species Antigen)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1525.jsonMercury Exposure and Toxicity (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1528.jsonMercury Exposure and Toxicity (Tests for Mercury [Quantitative] in Unspecified Specimen)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1532.jsonDrug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1533.jsonDrug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1534.jsonDrug Overdose and Poisoning [Non opioid] [Cannabinoid] (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1538.jsonDrug Overdose and Poisoning [Non opioid] [Other Drug] (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.154.jsonHepatitis C Virus Infection (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1540.jsonDrug Overdose and Poisoning [Non opioid] [CNS Stimulant] (Disorders) (ICD10CM)active2024-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1541.jsonDrug Overdose and Poisoning [Non opioid] [CNS Depressant] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1542.jsonDrug Overdose and Poisoning [Non opioid] [Hallucinogen] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1543.jsonDrug Overdose and Poisoning [Non opioid] [Cannabinoid] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1544.jsonDrug Overdose and Poisoning [Non opioid] [Analgesic] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1545.jsonDrug Overdose and Poisoning [Non opioid] [Other Drug] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1546.jsonDrug Overdose and Poisoning [Non opioid] (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1551.jsonMeningitis (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1552.jsonBacterial Meningitis (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1553.jsonFungal Meningitis (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1554.jsonParasitic Meningitis (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1555.jsonBacterial Meningitis (Disorders) (ICD10CM)active2024-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1559.jsonPhotophobia (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1562.jsonBacteria [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1563.jsonFungi [Causing Meningitis and Encephalitis] (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1564.jsonViruses [Causing Meningitis] (Organism or Substance in Lab Results)active2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1565.jsonViruses [Causing Meningitis] (Tests for Nucleic Acid)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1566.jsonViruses [Causing Meningitis] (Tests for Nucleic Acid in Cerebrospinal Fluid)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1567.jsonBacteria [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1574.jsonInvasive Group B Streptococcus (Disorders) (ICD10CM))active2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1577.jsonGroup A Streptococcus (Tests for Group A Strep by Culture and Identification Method)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1578.jsonGroup B Streptococcus (Tests for Group B Strep by Culture and Identification Method)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1580.jsonAnimal Bite [Dog] (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1581.jsonAnimal Bite [Mammal, Excluding Dogs] (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1582.jsonAnimal Bite [Excluding Mammals] (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1584.jsonAnimal Bite [Unspecified Animal] (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1585.jsonAnimal Bite [Dog] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1586.jsonAnimal Bite [Mammal, Excluding Dogs] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1587.jsonAnimal Bite [Excluding Mammals] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1588.jsonCadmium Exposure and Toxicity (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1604.jsonVaccine Adverse Event (Disorders) (ICD10CM)active2025-02usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1605.jsonVaccine Adverse Event (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1606.jsonVaccinia disease or adverse event  (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.161.jsonVibriosis (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1612.jsonBlepharitis [Unspecified Cause] (ICD10CM)active2024-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1613.jsonKeratitis [Unspecified Cause] (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1614.jsonKeratitis [Unspecified Cause] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1620.jsonAnaphylaxis [Unspecified Cause] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1626.jsonThrombocytopenic Purpura [Unspecified Cause] (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1640.jsonTyphus Fever (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1641.jsonTyphus Fever (Tests for Rickettsia Typhus Group IgG Antibody)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1642.jsonTyphus Fever (Tests for Rickettsia Typhus Group IgM Antibody)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1643.jsonTyphus Fever (Tests for Rickettsia Typhus Fever Group IgG Antibody [Quantitative] by Immunofluorescence)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1651.jsonChagas Disease (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1654.jsonChagas Disease (Tests for Trypanosoma cruzi Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1661.jsonCervical lymphadenopathy [Unspecified Cause] (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1662.jsonConjunctival injection (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1663.jsonDrying of lips (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1667.jsonEdema of hands or feet (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1676.jsonTests for Acinetobacter baumannii Nucleic Acidactive2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1677.jsonTests for Pseudomonas aeruginosa by Culture and Identification Methodactive2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1678.jsonTests for Pseudomonas aeruginosa Nucleic Acidactive2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1679.jsonPseudomonas aeruginosa (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1687.jsonNU_Gunshot Wound (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1688.jsonNU_Gunshot Wound (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.169.jsonGonorrhea [Neisseria gonorrhoeae] (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.170.jsonChlamydia trachomatis Infection (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1700.jsonEncephalitis [Viral] (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1702.jsonEncephalitis [Parasitic] (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1712.jsonBacteria [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1714.jsonParasites [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1715.jsonViruses [Causing Encephalitis] (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1716.jsonDrowning and Submersion (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1717.jsonDrowning and Submersion (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1718.jsonMotor Vehicle Injury (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1719.jsonMotor Vehicle Injury (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1720.jsonEnterovirus Infection [Non polio] (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1721.jsonEnterovirus Infection [Non polio] (Disorders) (ICD10CM)active2023-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1722.jsonEnterovirus Infection [Non polio] (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1723.jsonEnterovirus Infection [Non polio] (Tests for Non Polio Enterovirus by Culture and Identification Method)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1725.jsonEnterovirus Infection [Non polio] (Tests for Non Polio Enterovirus Nucleic Acid)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1726.jsonEnterovirus Infection [Non polio] (Tests for Non Polio Enterovirus in Cerebrospinal Fluid Nucleic Acid)active2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1735.jsonClostridium perfringens Infection (Tests for C perfringens by Culture and Identification Method)active2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1739.jsonHead Injury (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1740.jsonHead Injury (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1742.jsonBrain Injury [Traumatic] (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1745.jsonRotavirus Disease (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1746.jsonRotavirus Disease (Tests for Rotavirus Nucleic Acid)active2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1748.jsonChemical Pneumonitis (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1749.jsonChemical Pneumonitis (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1753.jsonStaphylococcal Enterotoxin B Poisoning (Tests for Staph aureus Enterotoxin B Nucleic Acid)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1755.jsonVomitus (Specimen Type) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1758.jsonAsbestosis (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.176.jsonWest Nile Virus Infection (Disorders) (ICD10CM)active2023-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1763.jsonByssinosis (Disorders) (ICD10CM)active2023-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1769.jsonFarmers Lung (Tests for Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1772.jsonFarmers Lung (Aspergillus fumigatus, Saccharopolyspora rectivirgula, or Thermoactinomyces vulgaris Antibody in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1773.jsonCLABSI (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1775.jsonOphthalmia neonatorum (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1778.jsonGenital herpes (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1779.jsonGenital herpes (Disorders) (ICD10CM)active2024-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1781.jsonHerpes (Tests for Herpes simplex virus Nucleic Acid)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1785.jsonElevated liver enzyme (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1786.jsonElevated liver enzyme (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1788.jsonTyphus Fever (Tests for Rickettsia Typhus Fever Group IgM Antibody [Quantitative] by Immunofluorescence)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1789.jsonGranuloma Inguinale (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1791.jsonUlcer [Genital, Perineal, or Perianal Area] (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1792.jsonUlcer [Genital, Perineal, or Perianal Area] (ICD10CM)active2023-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1797.jsonBronchial Wash (Specimen Type) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1800.jsonNontuberculous Mycobacteria Infection, Pulmonary (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1803.jsonBacteria (Tests in Sputum Specimen by Culture and Identification Method)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1819.jsonLouseborne relapsing fever (Tests for Borrelia species)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1820.jsonLouseborne relapsing fever (Tests for Borrelia species in Blood)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1823.jsonBorrelia species (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1824.jsonSpirochetes (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1829.jsonPolyarthritis [Unspecified Cause] (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1835.jsonRheumatoid nodules (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1842.jsonVentilator associated event (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1844.jsonLeishmaniasis (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1846.jsonLeishmaniasis (Tests for Leishmania species Nucleic Acid)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1847.jsonLeishmaniasis (Tests for Leishmania species Antibody)active2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1848.jsonLeishmania species (Tests by Microscopic Observation in Tissue)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.185.jsonBrucellosis (Disorders) (SNOMED)active2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1864.jsonTaeniasis (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1866.jsonTaeniasis (Organism or Substance in Lab Results)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.187.jsonDengue Virus Infection (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1875.jsonCysticercosis (Tests for Taenia solium Antibody)active2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1878.jsonSurgical Site Infection (Disorders) (SNOMED)active2024-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1880.jsonTests for Enterobacter spp., E. coli, or Klebsiella spp. Nucleic Acidactive2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1881.jsonNU_Tests for Enterobacteriaceae species Nucleic Acidactive2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1882.jsonCarbapenemase production (Organism or Substance in Lab Results)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1892.jsonToxoplasmosis (Disorders) (SNOMED)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1893.jsonToxoplasmosis (Disorders) (ICD10CM)active2023-06usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1895.jsonToxoplasmosis (Organism or Substance in Lab Results)active2023-06ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1897.jsonToxoplasmosis (Tests by Microscopic Observation)active2023-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1898.jsonToxoplasmosis (Tests for Toxoplasma gondii Nucleic Acid)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1901.jsonToxoplasmosis (Tests for Toxoplasma gondii Antibody)active2024-06usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1902.jsonOrthopox (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1908.jsonOrganisms (Tests by Electron Microscopic Observation)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1919.jsonFungi [Causing Meningitis] (Tests by Culture and Identification Method)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1923.jsonCoronary artery aneurysm (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1924.jsonCoronary artery dilatation (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1925.jsonEctatic coronary artery (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1926.jsonLeft ventricular ejection fraction [Decreased Level] (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1927.jsonCoronary artery aneurysm (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1928.jsonShock (SNOMED)active2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1929.jsonShock (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1930.jsonTroponin [Elevated Level] (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1931.jsonOral mucosa Inflammation (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1932.jsonOral mucosa Inflammation (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1933.jsonC reactive protein (Tests by Any Method)active2025-02usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1934.jsonLymphocytes [Concentration] (Tests by Any Method)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1935.jsonStrongyloidiasis (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1936.jsonStrongyloidiasis (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1937.jsonStrongyloidiasis (Tests for Strongyloides Nucleic Acid)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1938.jsonStrongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1939.jsonStrongyloidiasis (Tests for Strongyloides stercoralis IgG Antibody in Blood)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1940.jsonOrganisms (Tests by Microscopic Observation in Stool)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1941.jsonStrongyloidiasis (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1942.jsonStrongyloidiasis [Strongyloides stercoralis] (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1943.jsonJamestown Canyon Virus Diseases (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1944.jsonJamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Nucleic Acid)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1945.jsonJamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus IgM Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1946.jsonJamestown Canyon Virus Diseases (Tests for Jamestown Canyon Virus Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1947.jsonJamestown Canyon Virus Diseases (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1948.jsonKeystone Virus Diseases (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1949.jsonLa Crosse Virus Diseases (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1950.jsonSnowshoe hare Virus Diseases (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1951.jsonTrivittatus Virus Diseases (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1952.jsonLa Crosse Virus Diseases (Tests for La Crosse Virus Nucleic Acid)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1953.jsonSnowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Nucleic Acid)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1954.jsonLa Crosse Virus Diseases (Tests for La Crosse Virus IgM Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1955.jsonSnowshoe hare Virus Diseases (Tests for Snowshoe hare Virus IgM Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1956.jsonLa Crosse Virus Diseases (Tests for La Crosse Virus Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1957.jsonSnowshoe hare Virus Diseases (Tests for Snowshoe hare Virus Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1958.jsonTrivittatus Virus Diseases (Tests for Trivittatus Virus Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1959.jsonKeystone Virus Diseases (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1960.jsonLa Crosse Virus Diseases (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1961.jsonSnowshoe hare Virus Diseases (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1962.jsonTrivittatus Virus Diseases (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1963.jsonHepatitis C Virus Infection, Perinatal (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1964.jsonEncephalomyelitis (SNOMED)active2024-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1965.jsonEncephalomyelitis (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1966.jsonDrug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1967.jsonDrug Overdose and Poisoning [Non opioid] [Muscle Relaxant] (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1968.jsonHepatitis D Virus Infection (Disorders) (SNOMED)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1969.jsonHepatitis D Virus Infection (Disorders) (ICD10CM)active2023-01usicd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1970.jsonNU_Hepatitis D Virus Infection (Tests for hepatitis D virus total or IgG Antibody)active2024-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1971.jsonHepatitis D Virus Infection (Tests for hepatitis D virus IgM Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1972.jsonHepatitis D Virus Infection (Tests for hepatitis D virus Nucleic Acid)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1973.jsonHepatitis D Virus Infection (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1974.jsonBaylisascariasis (Disorders) (SNOMED)active2025-02ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1975.jsonBaylisascariasis (Organism or Substance in Lab Results)active2023-01ussct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1976.jsonBaylisascariasis (Tests for Baylisascaris species Antibody)active2023-01usloinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1146.1978.jsonLarva Migrans (Neural, Ocular, or Visceral) (SNOMED)active2024-01ussct